KIT and neoplasm: To verify this hypothesis, we analyzed expression of several markers on GFP+ tumor cells that were previously thought to characterize cancer stem cells: c-Kit [26], Sca-1 [27], CD133 [28–30], CD49f [31], and CXCR4 [30, 32, 33].